Cargando…

Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA)

SIMPLE SUMMARY: Prostate cancer (PCa) is the second most common cancer and one of the highestcauses of cancer deaths among men. The presence of lymph node metastases (LNM) is the strongest prognostic factor. Histological detection of LNM is the gold standard for LN staging. In clinical practice, onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Engels, Svenja, Brautmeier, Lutz, Reinhardt, Lena, Wasylow, Clara, Hasselmann, Friederike, Henke, Rolf P., Wawroschek, Friedhelm, Winter, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961354/
https://www.ncbi.nlm.nih.gov/pubmed/33807774
http://dx.doi.org/10.3390/cancers13051117
_version_ 1783665241192660992
author Engels, Svenja
Brautmeier, Lutz
Reinhardt, Lena
Wasylow, Clara
Hasselmann, Friederike
Henke, Rolf P.
Wawroschek, Friedhelm
Winter, Alexander
author_facet Engels, Svenja
Brautmeier, Lutz
Reinhardt, Lena
Wasylow, Clara
Hasselmann, Friederike
Henke, Rolf P.
Wawroschek, Friedhelm
Winter, Alexander
author_sort Engels, Svenja
collection PubMed
description SIMPLE SUMMARY: Prostate cancer (PCa) is the second most common cancer and one of the highestcauses of cancer deaths among men. The presence of lymph node metastases (LNM) is the strongest prognostic factor. Histological detection of LNM is the gold standard for LN staging. In clinical practice, only fractions of LNs are examined histopathologically, resulting in missed (micro-)metastases. Biomolecular techniques can enhance the identification of LNM but are not routinely used because of high cost. One-step nucleic acid amplification (OSNA) analyzes the entire LN by detecting cytokeratin 19 mRNA as a surrogate for LNM requiring less effort and allowing intraoperative application. To verify the reliability of OSNA for the first time in PCa, we examined LNs of patients undergoing prostatectomy and sentinel lymphadenectomy. Results were compared with histopathological and immunohistochemistry findings. OSNA identified LNM equivalent to, or in cases of micrometastases, even better than enhanced histopathology, and might be useful in intraoperative decision-making in personalized LN surgery. ABSTRACT: Background: In clinical routine, only fractions of lymph nodes (LNs) are examined histopathologically, often resulting in missed (micro-)metastases and incorrect staging of prostate cancer (PCa). One-step nucleic acid amplification (OSNA) analyzes the entire LN by detecting cytokeratin 19 (CK19) mRNA as a surrogate for LN metastases requiring less effort than conventional biomolecular techniques. We aimed to evaluate performance of OSNA in detecting sentinel LN (SLN) metastases in PCa. Methods: SLNs (n = 534) of 64 intermediate- or high-risk PCa patients undergoing radical prostatectomy with extended and sentinel-guided lymphadenectomy were cut into slices and alternatingly assigned to OSNA and histopathology (hematoxylin-eosin staining, CK19, and CK AE1/AE3 immunohistochemistry). Sensitivity and specificity of OSNA and concordance and measure of agreement (Cohen’s kappa (κ)) between OSNA and histopathology were assessed. Results: Histopathology revealed metastases in 76 SLNs. Sensitivity and specificity of OSNA were 84.2% and 96.1%, respectively. Discordant results were recorded for 30 of 534 SLNs, revealing high concordance (94.4%). Twenty-four discordant cases were classified as micrometastases, indicating a possible allocation bias. In 18 cases, positive results were conferred only by OSNA resulting in seven LN-positive patients who were missed by histopathology. Overall, the level of agreement was high (κ = 0.78). Conclusions: OSNA provided a diagnosis that was as least as accurate as detailed histological examination and might improve LN staging in PCa.
format Online
Article
Text
id pubmed-7961354
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79613542021-03-17 Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) Engels, Svenja Brautmeier, Lutz Reinhardt, Lena Wasylow, Clara Hasselmann, Friederike Henke, Rolf P. Wawroschek, Friedhelm Winter, Alexander Cancers (Basel) Article SIMPLE SUMMARY: Prostate cancer (PCa) is the second most common cancer and one of the highestcauses of cancer deaths among men. The presence of lymph node metastases (LNM) is the strongest prognostic factor. Histological detection of LNM is the gold standard for LN staging. In clinical practice, only fractions of LNs are examined histopathologically, resulting in missed (micro-)metastases. Biomolecular techniques can enhance the identification of LNM but are not routinely used because of high cost. One-step nucleic acid amplification (OSNA) analyzes the entire LN by detecting cytokeratin 19 mRNA as a surrogate for LNM requiring less effort and allowing intraoperative application. To verify the reliability of OSNA for the first time in PCa, we examined LNs of patients undergoing prostatectomy and sentinel lymphadenectomy. Results were compared with histopathological and immunohistochemistry findings. OSNA identified LNM equivalent to, or in cases of micrometastases, even better than enhanced histopathology, and might be useful in intraoperative decision-making in personalized LN surgery. ABSTRACT: Background: In clinical routine, only fractions of lymph nodes (LNs) are examined histopathologically, often resulting in missed (micro-)metastases and incorrect staging of prostate cancer (PCa). One-step nucleic acid amplification (OSNA) analyzes the entire LN by detecting cytokeratin 19 (CK19) mRNA as a surrogate for LN metastases requiring less effort than conventional biomolecular techniques. We aimed to evaluate performance of OSNA in detecting sentinel LN (SLN) metastases in PCa. Methods: SLNs (n = 534) of 64 intermediate- or high-risk PCa patients undergoing radical prostatectomy with extended and sentinel-guided lymphadenectomy were cut into slices and alternatingly assigned to OSNA and histopathology (hematoxylin-eosin staining, CK19, and CK AE1/AE3 immunohistochemistry). Sensitivity and specificity of OSNA and concordance and measure of agreement (Cohen’s kappa (κ)) between OSNA and histopathology were assessed. Results: Histopathology revealed metastases in 76 SLNs. Sensitivity and specificity of OSNA were 84.2% and 96.1%, respectively. Discordant results were recorded for 30 of 534 SLNs, revealing high concordance (94.4%). Twenty-four discordant cases were classified as micrometastases, indicating a possible allocation bias. In 18 cases, positive results were conferred only by OSNA resulting in seven LN-positive patients who were missed by histopathology. Overall, the level of agreement was high (κ = 0.78). Conclusions: OSNA provided a diagnosis that was as least as accurate as detailed histological examination and might improve LN staging in PCa. MDPI 2021-03-05 /pmc/articles/PMC7961354/ /pubmed/33807774 http://dx.doi.org/10.3390/cancers13051117 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Engels, Svenja
Brautmeier, Lutz
Reinhardt, Lena
Wasylow, Clara
Hasselmann, Friederike
Henke, Rolf P.
Wawroschek, Friedhelm
Winter, Alexander
Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA)
title Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA)
title_full Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA)
title_fullStr Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA)
title_full_unstemmed Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA)
title_short Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA)
title_sort evaluation of fast molecular detection of lymph node metastases in prostate cancer patients using one-step nucleic acid amplification (osna)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961354/
https://www.ncbi.nlm.nih.gov/pubmed/33807774
http://dx.doi.org/10.3390/cancers13051117
work_keys_str_mv AT engelssvenja evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna
AT brautmeierlutz evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna
AT reinhardtlena evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna
AT wasylowclara evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna
AT hasselmannfriederike evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna
AT henkerolfp evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna
AT wawroschekfriedhelm evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna
AT winteralexander evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna